Senti Biosciences Inc.

3.58
0.34 (10.35%)
At close: Apr 02, 2025, 3:59 PM
10.35%
Bid 3
Market Cap 17.29M
Revenue (ttm) n/a
Net Income (ttm) n/a
EPS (ttm) -12.03
PE Ratio (ttm) -0.3
Forward PE -2.4
Analyst Strong Buy
Ask 4
Volume 8,449
Avg. Volume (20D) 48,501
Open 3.19
Previous Close 3.24
Day's Range 3.16 - 3.58
52-Week Range 1.52 - 16.94
Beta 2.53

About SNTI

Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor onc...

Industry Biotechnology
Sector Healthcare
IPO Date May 26, 2021
Employees 34
Stock Exchange NASDAQ
Ticker Symbol SNTI
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for SNTI stock is "Strong Buy." The 12-month stock price forecast is $12, which is an increase of 235.20% from the latest price.

Stock Forecasts

Next Earnings Release

Senti Biosciences Inc. is scheduled to release its earnings on Apr 8, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+362.96%
Senti Biosciences shares are trading higher after ... Unlock content with Pro Subscription
7 months ago
+10.15%
Senti Biosciences shares are trading higher after the company announced a year-over-year increase in Q2 EPS results.